Thyroid News and Research

RSS

New study shows Bisphenol A exposure through diet has been underestimated

A new University of Missouri study shows that the exposure to the controversial chemical Bisphenol A (BPA) through diet has been underestimated by previous lab tests.

6 Jun 2011

Researcher finds thyroid cancer gene inhibits spread of malignant cells

A mutant gene long thought to accelerate tumor growth in thyroid cancer patients actually inhibits the spread of malignant cells, showing promise for novel cancer therapies, a Mayo Clinic study has found.

6 Jun 2011

Older adults with subclinical hyperthyroidism may face higher risk of dying

A common hormone abnormality in older adults—a mild form of overactive thyroid called subclinical hyperthyroidism—is linked to a much higher risk of dying, a new study finds. The results will be presented Sunday at The Endocrine Society's 93rd Annual Meeting in Boston.

6 Jun 2011

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.

4 Jun 2011

Delayed treatment could prove effective in certain medical conditions

In today's fast-paced world, waiting — whether it's at the doctor's office, in line at the grocery store or for an Internet connection — is rarely considered a good thing.

3 Jun 2011

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Preliminary results of a Phase II single-arm study to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's lenvatinib demonstrated an Objective Response Rate of 59% (34/58, 95% CI: 45-71), based on an updated investigator assessment, in patients with advanced radioiodine (RAI)-refractory differentiated thyroid cancer.

1 Jun 2011

Facelift incision with no-neck-scar approach safe and effective for thyroid patients

A facelift incision and robotics can help surgeons safely remove a portion of a diseased thyroid from some patients without the characteristic neck scar.

1 Jun 2011

ATA recognizes 4th Annual World Thyroid Day

The American Thyroid Association, in cooperation with sister international thyroid societies, the European Thyroid Association, the Asia & Oceania Thyroid Association, and the Latin American Thyroid Society, recognizes the 4th Annual World Thyroid Day, May 25, 2011.

26 May 2011

Novel way to immobilise radioactive iodine

A novel way to immobilise radioactive forms of iodine using a microwave, has been discovered by an expert at the University of Sheffield.

26 May 2011

Exposure to common fire retardant may cause developmental malformations, behavioral changes and death

A new study by Baylor University environmental health researchers found that zebra fish exposed to several different technical mixtures of polybrominated diphenyl ethers (PBDEs) - a common fire retardant - during early development can cause developmental malformations, changes in behavior and death.

25 May 2011

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.

24 May 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

Exelixis, Inc. today announced the results of the phase 1 clinical trial of cabozantinib in patients with advanced solid tumors or lymphoma have been published in the current issue of the Journal of Clinical Oncology.

24 May 2011

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present preclinical data demonstrating VB-111's potential synergy and additive therapeutic effect when administered in combination with the conventional chemotherapy cancer treatments.

20 May 2011

Bioengineering students redesign pediatric mannequin

Rice University bioengineering students have modified a child-size training mannequin to give medical students hands-on pediatric experience so that real patients can be spared further stress and pain.

17 May 2011

Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide

The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a new study.

17 May 2011

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

For diagnosing head and neck ailments, tests that use radiation are always less desirable than those that don't. Otolaryngologists have a wide range of techniques available to them, including CT or "CAT" scans, MRI and ultrasound.

12 May 2011

Study evaluates link between thyroid autoantibodies, miscarriage and preterm birth

GW Researcher Dr. Alex Stagnaro-Green, and colleagues, have contributed an editorial featured in the May 14 issue of the British Medical Journal reviewing a study that evaluated the relationship between thyroid autoantibodies and both miscarriage and preterm birth.

11 May 2011

University of California, Irvine Medical Center introduce Journal of Adolescent and Young Adult Oncology

A new effort led by a University of California, Irvine Medical Center oncologist seeks to improve cancer survival for adolescents and young adults. Dr. Leonard S. Sender has long advocated changing the approach oncologists take when treating patients and survivors aged 15 to 39.

7 May 2011

TPO antibodies linked to abnormal thyroid levels in women after giving birth

Almost 1 in 20 women who gives birth will go on to develop thyroid problems within two years, according to a new study presented at the European Congress of Endocrinology in Rotterdam. This could have significant implications for the future health of the mother and child, as well as potentially presenting problems for future pregnancies.

4 May 2011

Porter Adventist Hospital introduces new institute for robotic surgery

Robotic surgery, once the stuff of science fiction, has for some years been recognized as an important advance in surgical technique and patient experience. Now, at Porter Adventist Hospital, a comprehensive team of surgeons and staff are helping to bring in a new era in robotic surgery.

2 May 2011

Thyroid News and Research

New study shows Bisphenol A exposure through diet has been underestimated

Researcher finds thyroid cancer gene inhibits spread of malignant cells

Older adults with subclinical hyperthyroidism may face higher risk of dying

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

Delayed treatment could prove effective in certain medical conditions

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Facelift incision with no-neck-scar approach safe and effective for thyroid patients

ATA recognizes 4th Annual World Thyroid Day

Novel way to immobilise radioactive iodine

Exposure to common fire retardant may cause developmental malformations, behavioral changes and death

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

Journal of Clinical Oncology publishes Exelixis' cabozantinib phase 1 trial results in lymphoma

VBL to present positive VB-111 preclinical data in metastatic lung cancer at 14th ASGCT

Bioengineering students redesign pediatric mannequin

Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide

Researcher finds ultrasound as effective as CT scans for head and neck diagnoses

Study evaluates link between thyroid autoantibodies, miscarriage and preterm birth

University of California, Irvine Medical Center introduce Journal of Adolescent and Young Adult Oncology

TPO antibodies linked to abnormal thyroid levels in women after giving birth

Porter Adventist Hospital introduces new institute for robotic surgery

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News